Abstract 18939: Pregnancy Outcomes in Women with Eisenmenger Syndrome: A Cohort Study from a National Referral Center in Mexico City
Abstract
Background: Eisenmenger syndrome (ES) is a severe form of congenital heart disease characterized by pulmonary arterial hypertension and right-to-left or bidirectional intracardiac shunting. Pregnancy in women with ES is associated with poor tolerance to the physiological cardiovascular changes of gestation, resulting in a high risk of maternal and fetal complications and historically elevated maternal mortality. However, data regarding pregnancy outcomes in Latin American populations remain limited. Methods: We conducted a retrospective cohort study at a tertiary referral center in Mexico City between January 2005 and January 2025. All pregnancies in women with ES were included, including live births, miscarriages, ectopic pregnancies, and elective terminations. Maternal, obstetric, and neonatal outcomes were obtained from institutional records of the Adult Congenital Heart Disease Department. Results: Among 45 women with ES, 22 experienced pregnancy during the study period, accounting for 57 pregnancies. Of these, 40 resulted in live births (18 cesarean deliveries and 22 vaginal deliveries), while 17 ended in abortion or miscarriage. Maternal mortality occurred in five patients (22.7%). Four women experienced major maternal complications, including eclampsia (n=1), preeclampsia (n=1), peripartum cardiomyopathy (n=1), and premature rupture of membranes (n=1). Among the 40 live births, mean birth weight was 2329 ± 636 g and mean gestational age was 34.8 ± 3.1 weeks. Low birth weight (<2500 g) occurred in 22 neonates (55%), prematurity in 25 births (62.5%), and four neonatal deaths were recorded. Conclusions: Pregnancy in women with Eisenmenger syndrome remains associated with maternal mortality and adverse neonatal outcomes, particularly prematurity and low birth weight, despite advances in multidisciplinary care. These findings highlight the importance of preconception counseling by congenital heart disease and cardio-obstetric specialists to ensure that patients fully understand the substantial risks associated with pregnancy.